Paradigm shift: should preoperative 3D reconstruction models become mandatory before hepatectomy for hepatocellular carcinoma (HCC)? Results of a multicenter prospective trial.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
03 2023
Historique:
received: 21 09 2022
accepted: 16 11 2022
pubmed: 30 1 2023
medline: 8 3 2023
entrez: 29 1 2023
Statut: ppublish

Résumé

A preoperative surgical strategy before hepatectomy for hepatocellular carcinoma is fundamental to minimize postoperative morbidity and mortality and to reach the best oncologic outcomes. Preoperative 3D reconstruction models may help to better choose the type of procedure to perform and possibly change the initially established plan based on conventional 2D imaging. A non-randomized multicenter prospective trial with 136 patients presenting with a resectable hepatocellular carcinoma who underwent open or minimally invasive liver resection. Measurement was based on the modification rate analysis between conventional 2D imaging (named "Plan A") and 3D model analysis ("Plan B"), and from Plan B to the final procedure performed (named "Plan C"). The modification rate from Plan B to Plan C (18%) was less frequent than the modification from Plan A to Plan B (35%) (OR = 0.32 [0.15; 0.64]). Concerning secondary objectives, resection margins were underestimated in Plan B as compared to Plan C (-3.10 mm [-5.04; -1.15]). Preoperative 3D imaging is associated with a better prediction of the performed surgical procedure for liver resections in HCC, as compared to classical 2D imaging.

Sections du résumé

BACKGROUND
A preoperative surgical strategy before hepatectomy for hepatocellular carcinoma is fundamental to minimize postoperative morbidity and mortality and to reach the best oncologic outcomes. Preoperative 3D reconstruction models may help to better choose the type of procedure to perform and possibly change the initially established plan based on conventional 2D imaging.
METHODS
A non-randomized multicenter prospective trial with 136 patients presenting with a resectable hepatocellular carcinoma who underwent open or minimally invasive liver resection. Measurement was based on the modification rate analysis between conventional 2D imaging (named "Plan A") and 3D model analysis ("Plan B"), and from Plan B to the final procedure performed (named "Plan C").
RESULTS
The modification rate from Plan B to Plan C (18%) was less frequent than the modification from Plan A to Plan B (35%) (OR = 0.32 [0.15; 0.64]). Concerning secondary objectives, resection margins were underestimated in Plan B as compared to Plan C (-3.10 mm [-5.04; -1.15]).
CONCLUSION
Preoperative 3D imaging is associated with a better prediction of the performed surgical procedure for liver resections in HCC, as compared to classical 2D imaging.

Identifiants

pubmed: 36710089
pii: S1365-182X(22)01666-5
doi: 10.1016/j.hpb.2022.11.007
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-300

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Emanuele Felli (E)

Unité Chirurgie HBP, Pôle hépato-digestif Nouvel Hôpital Civil, Strasbourg, France; Institut of Viral and Liver Disease, Inserm U1110, Strasbourg, France; IHU Strasbourg - Institut de Chirurgie Guidée par l'image, Strasbourg, France; IRCAD, Research Institute Against Digestive Cancer, Strasbourg, France.

Emmanuel Boleslawski (E)

University Lille, CHU Lille, Service de Chirurgie Digestive et Transplantations, Lille, France; INSERM, U1193, Villejuif, France.

Daniele Sommacale (D)

Department of Digestive and Hepatobiliary and Pancreatic Surgery, AP-HP, Hôpital Henri-Mondor, F-94010, Créteil, France; INSERM U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", Créteil, Assistance Publique-Hôpitaux de Paris, France; Department of Oncological Digestive Surgery, Hepatobiliary and Pancreatic Surgery Unit, University Reims Champagne-Ardenne, Reims, France.

Olivier Scatton (O)

Department of Hepatobiliary Surgery and Liver Transplantation, Pitié Salpêtrière Hospital, Sorbonne Université, Paris, France.

Raffaele Brustia (R)

Department of Digestive and Hepatobiliary and Pancreatic Surgery, AP-HP, Hôpital Henri-Mondor, F-94010, Créteil, France.

Lilian Schwarz (L)

Digestive Surgery Department, Rouen University Hospital, Rouen, France.

Daniel Cherqui (D)

Centre Hepato-Biliaire, AP-HP Paul Brousse Hospital, Paris-Saclay University, Villejuif, France.

Thomas Zacharias (T)

Service Chirurgie Digestive, Hôpital Emile Muller Mulhouse, France.

Alexis Laurent (A)

Department of Digestive and Hepatobiliary and Pancreatic Surgery, AP-HP, Hôpital Henri-Mondor, F-94010, Créteil, France.

Jean-Yves Mabrut (JY)

Service de chirurgie générale, digestive et Transplantation hépatique et intestinale, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Lyon I, Lyon, France; Cancer Research Center of Lyon, Institut national de la santé et de la recherche médicale (INSERM), Unité 1052, Lyon, France.

Catherine Schuster (C)

INSERM, U1193, Villejuif, France.

Benoit Gallix (B)

IHU Strasbourg - Institut de Chirurgie Guidée par l'image, Strasbourg, France.

Patrick Pessaux (P)

Unité Chirurgie HBP, Pôle hépato-digestif Nouvel Hôpital Civil, Strasbourg, France; Institut of Viral and Liver Disease, Inserm U1110, Strasbourg, France; IHU Strasbourg - Institut de Chirurgie Guidée par l'image, Strasbourg, France; IRCAD, Research Institute Against Digestive Cancer, Strasbourg, France. Electronic address: patrick.pessaux@chru-strasbourg.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH